The same group used diphtheria toxin receptor-expressing transgenic mice to study the role of FAP in PDAC and found that eliminating FAP+ cells significantly reduces tumor growth, which is related to CD4+/CD8+ T-cell activity. This evidence concerns the gene HBEGF and neoplasm.